The CSE proudly welcomed Field Trip Health Ltd. (CSE:FTRP) to join the Exchange in our first virtual Market Open, on October 6th, 2020.
Field Trip Health is a global leader in the development and delivery of psychedelic therapies for mental health, including depression. The company conducts advanced research on plant-based psychedelics and is leading the development of the next generation of psychedelic molecules. Currently operating within North America and via Field Trip Digital, the company’s technology division, Field Trip Health blends psychedelic-enhanced therapy, mindfulness, and self-care with a series of sessions with trained psychotherapists. This enables them to offer a more personalized approach to mental wellness, as opposed to traditional pharmaceutical and psychiatric treatments.
In celebration of the momentous occasion, CSE CEO Richard Carleton stated, “It’s a real pleasure – in fact, it’s our favourite part of all of our jobs: to welcome new issuers to the Exchange.” He remarked, “[The CSE is] very active in the psychedelic space. We’ve got many, many people who are very excited [about] the therapeutic benefits, the lifestyle benefits, and wellness – and improvement in overall human health – that this sector promises.”
James Black, the CSE’s Vice President of Listings Development, added, “Welcome to the Exchange. Thanks for being a part of the family. We’re very, very excited to welcome you today and, for the first time, to give you a virtual welcome. We look forward to working with you. We’re really proud of the listing; we’re proud of everything that you’re aiming to do. Let’s be a part of something successful.”
Several members of the Field Trip Health team were present at the virtual event, including Founder and Executive Chairman Ronan Levy, who led the countdown and “rang” a makeshift “opening bell” of his own.
For more details about the CSE, including information on upcoming Market Opens, please visit the CSE website or follow us on social media.
